Because semaglutide slows stomach emptying, eating large meals or very fatty foods may trigger nausea
Accelerated callus formation or earlier bridging on imaging suggests peptide benefits
In addition to weight loss, these drugs have been shown to protect against cardiovascular disease and other conditions related to excess weight, such as diabetes, high blood pressure, and high cholesterol
Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
Together, they help fade dark spots, scars, and sun damage while improving elasticity and radiance with consistent use
